The MDM2-p53 pathway revisited

por Nag, Subhasree, Qin, Jiangjiang, Srivenugopal, Kalkunte S., Wang, Minghai, Zhang, Ruiwen
Publicado 2013

Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action

por Nag, Subhasree Ashok, Qin, Jiang-Jiang, Wang, Wei, Wang, Ming-Hai, Wang, Hui, Zhang, Ruiwen
Publicado 2012

RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo

por Wang, Wei, Cheng, Jianwen, Qin, Jiang-Jiang, Voruganti, Sukesh, Nag, Subhasree, Fan, Jia, Gao, Qiang, Zhang, Ruiwen
Publicado 2014

Natural Product Ginsenoside 25-OCH(3)-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2

por Wang, Wei, Zhang, Xu, Qin, Jiang-Jiang, Voruganti, Sukesh, Nag, Subhasree Ashok, Wang, Ming-Hai, Wang, Hui, Zhang, Ruiwen
Publicado 2012

Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate...

por Voruganti, Sukesh, Qin, Jiang-Jiang, Sarkar, Sushanta, Nag, Subhasree, Walbi, Ismail A., Wang, Shu, Zhao, Yuqing, Wang, Wei, Zhang, Ruiwen
Publicado 2015

KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology

por Wang, Wei, Ao, Lin, Rayburn, Elizabeth R., Xu, Hongxia, Zhang, Xiangrong, Zhang, Xu, Nag, Subhasree Ashok, Wu, Xuming, Wang, Ming-Hai, Wang, Hui, Van Meir, Erwin G., Zhang, Ruiwen
Publicado 2012